Latest From Biotech Now

BIO’s One-on-One Partnering™ and the Winning Pitch – 2016 BIO Investor Forum

partnering-HP-300x312

BIO’s One-on-One Partnering™ system will facilitate over 2,000 partnering meetings at this year’s BIO Investor Forum. Partnering activity is at a record high, with 60% more requests already compared to any previous year and 50% more meetings scheduled. The system is easier to use than ever. It includes a mobile app, integration with Outlook, Gmail or other calendars, and the ability to browse and schedule sessions and company presentations. BIO’s partnering system is built atop Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

Post-election Scenarios to Microbiome Therapies—Diverse Panels at 2016 BIO Investor Forum

us_flag

Government policy and regulation, investment trends, latest discoveries, drug development, licensing and other topics will be covered during panel sessions at the 15th annual BIO Investor Forum Oct 18-19 in San Francisco. Among the varied educational topics covered during the conference is one that can only occur every four years: the presidential election. The presidential campaign is generating interest from all sectors of American society—and rightfully so. The decision made in November will impact all Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

Should We Bring Extinct Species Back From the Dead?

Woolly_mammoth

For decades the notion of “de-extinction” hovered on the scientific fringes, Science‘s David Schultz stated in his recent article. Now new advances in genetic engineering, especially the CRISPR-Cas9 revolution, have researchers believing that it’s time to start thinking seriously about which animals we might be able to bring back, and which ones would do the most good for the ecosystems they left behind. In “Should we bring extinct species back from the dead?,” David Schultz explains what is de-extinction, Read More >

Food And Agriculture  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Closing the Gender Gap in Biotech through SBIR/STTR Funding

sbir-sttr

Although progress has been made, there is no denying the biotech industry continues to have a large gender gap. Women hold only 16 percent of the senior management posts at the top pharma companies, and of senior executive positions at emerging companies — the 10 companies that raised most in venture capital A rounds in 2014 — only 12 (17 percent) were filled by women.* The National Center for Advancing Translational Sciences (NCATS), part of Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Why GMOs Are a Necessity

GMO-soybeans-665x385-150x150

After 20 years, the data are in:  Genetic modification boosts crop yields by 21 percent and cuts pesticides by 37 percent.  The Wall Street Journal ran an op-ed authored by Rob Fraley, executive vice president and chief technology officer of Monsanto, on how GMO’s benefit farmers and the environment: Genetically modified crops, which have generated both controversy and widespread adoption, are hitting 20-year milestones. Perhaps the anniversary slipped your mind, but 1997 was a dark Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,